SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Palomar Medical Technologies, Inc.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BMALONEY who wrote (568)10/1/1997 9:49:00 AM
From: Spank   of 708
 
from wsj:

Palomar Medical Technologies Inc., Beverly, Mass., seeking to shed non-core businesses and concentrate on its core cosmetic laser products, said it will take a $23 million restructuring charge in the third quarter ended yesterday. The company also said it expects a $14 million operating loss for the quarter. For the year-earlier quarter, Palomar reported a loss of $3.9 million on revenue of $24.6 million. Palomar said the restructuring charge includes $21 million in non-cash
charges all related to non-core businesses. Also included is a $2 million reserve for severance costs stemming from consolidating several functions. Yesterday's announcement was made after the market closed. In Nasdaq Stock Market trading, Palomar shares closed at $3, down 1/32.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext